STYLAGE® XL BI-SOFT® with Lidocaine

Stylage® Bi-Soft® XL must be injected into the area to be treated, where they will generate volume. The products will then be resorbed slowly over time. The duration of the products depends on the patient’s skin type and the depth of injection.

A hyaluronic-acid injectable gel indicated for the restoration or augmentation of facial volume by injection into the deep dermis or subcutaneously. Lidocaine hydrochloride is intended to reduce the pain associated with the injection.

Stylage® Bi-Soft® XL is an injectable hyaluronic-acid volumiser specifically designed to restore facial contours which have been lost over time. By restoring facial volume, This formulation provides a more harmonious balance to the facial features by recontouring the cheeks, cheekbones, chin, and jawline for a fuller, softer, more youthful appearance. Stylage® Bi-Soft® XL can also help treat skin sagging. Use Stylage® in the deep dermis or subcutaneous. Contains lidocaine, a powerful anaesthetic, for a more comfortable injection.

Contraindications:

• The products must not be used:
  • In combination with a peeling, laser treatment, or dermabrasion. The practitioner shall decide upon the necessary waiting period after these treatments before the injection;
  • In areas where the skin is thin (e.g. the forehead and the periorbital region, including the eyelids, the under-eye shadows, the crow’s feet), in areas where the vascular system is exposed (e.g. the glabellar region) and in the lips;
  • In patients with a tendency to develop hypertrophic scars;
  • In patients with a known hypersensitivity to one of the ingredients;
  • In women who are pregnant or breastfeeding, or in children;
  • In areas, or near areas, with inflammatory or infectious skin problems (acne, herpes, etc.).
• Furthermore, Stylage® XL must not be used:
  • In patients with a known hypersensitivity to amide-type local anaesthetics;
  • In patients with porphyria.

After-care:

• Recommend using a sunscreen with a high protection factor during the two weeks following treatment.
• Advise the patient not to wear make-up during the 12 hours following the injection and avoid exposing the treated area to intense heat (UV, sauna, steam room) or extreme cold, at least until any potential post-injection swelling or redness disappear.
• Recommend that the patient avoid any massage or compression of the injected area for the first 3 days after the injection.
• Recommend that the patient avoid the sauna, steam room, and vigorous sports during the first week after injection.